Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-018809
Filing Date
2025-02-12
Accepted
2025-02-12 16:00:20
Documents
68
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20241231.htm   iXBRL 10-Q 1412832
2 EX-31.1 meip-ex31_1.htm EX-31.1 16828
3 EX-32.1 meip-ex32_1.htm EX-32.1 7243
4 GRAPHIC img105009805_0.jpg GRAPHIC 132946
  Complete submission text file 0000950170-25-018809.txt   6731009

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20241231.xsd EX-101.SCH 1168365
71 EXTRACTED XBRL INSTANCE DOCUMENT meip-20241231_htm.xml XML 933685
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41827 | Film No.: 25614662
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)